Correlation Between Recursion Pharmaceuticals and Alkame Holdings
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Alkame Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Alkame Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Alkame Holdings, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Alkame Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Alkame Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Alkame Holdings.
Diversification Opportunities for Recursion Pharmaceuticals and Alkame Holdings
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Recursion and Alkame is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Alkame Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alkame Holdings and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Alkame Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alkame Holdings has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Alkame Holdings go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Alkame Holdings
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to under-perform the Alkame Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Recursion Pharmaceuticals is 3.18 times less risky than Alkame Holdings. The stock trades about -0.01 of its potential returns per unit of risk. The Alkame Holdings is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 0.02 in Alkame Holdings on September 12, 2024 and sell it today you would lose (0.01) from holding Alkame Holdings or give up 50.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. Alkame Holdings
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| Alkame Holdings |
Recursion Pharmaceuticals and Alkame Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and Alkame Holdings
The main advantage of trading using opposite Recursion Pharmaceuticals and Alkame Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Alkame Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alkame Holdings will offset losses from the drop in Alkame Holdings' long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| Alkame Holdings vs. V Group | Alkame Holdings vs. Fbec Worldwide | Alkame Holdings vs. Hiru Corporation | Alkame Holdings vs. Bank of America |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |